AGÕæÈ˹ٷ½

STOCK TITAN

[8-K] XCEL BRANDS INC. Reports Material Event

Filing Impact
(High)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

On 17 June 2025, Xcel Brands, Inc. (NASDAQ: XELB) convened a Special Meeting where shareholders voted on two critical corporate actions. A quorum of 1,637,039 shares (â‰�68.6% of the 2,386,325 outstanding) was present.

1. Warrant Exercise Proposal. Shareholders approved, under Nasdaq Rule 5635, the issuance of common stock exceeding 19.99% of outstanding shares upon exercise of refinancing-related warrants. The motion passed with 1,020,922 votes for, 5,503 against, 540 abstentions and 610,074 broker non-votes. The approval removes a regulatory barrier and allows the company to complete its April 21, 2025 refinancing terms.

2. Reverse Stock Split Proposal. Investors authorised the Board, at its discretion, to execute a reverse split between 1-for-2 and 1-for-5 any time before 25 March 2026. This measure passed decisively with 1,613,691 votes for, 23,019 against and 329 abstentions. The flexibility could help Xcel maintain Nasdaq listing standards by boosting its per-share price.

No additional matters required a vote. Collectively, the approvals provide management with enhanced capital-raising and compliance tools, though they introduce potential dilution and share-count reduction depending on future execution.

Il 17 giugno 2025, Xcel Brands, Inc. (NASDAQ: XELB) ha tenuto un'Assemblea Straordinaria durante la quale gli azionisti hanno votato su due importanti decisioni aziendali. Era presente un quorum di 1.637.039 azioni (circa il 68,6% delle 2.386.325 azioni in circolazione).

1. Proposta di esercizio dei warrant. Gli azionisti hanno approvato, ai sensi della Regola Nasdaq 5635, l'emissione di azioni ordinarie che superano il 19,99% delle azioni in circolazione in seguito all'esercizio di warrant legati al rifinanziamento. La mozione è stata approvata con 1.020.922 voti favorevoli, 5.503 contrari, 540 astensioni e 610.074 voti non espressi dai broker. L'approvazione elimina un ostacolo normativo e permette all'azienda di completare i termini del rifinanziamento del 21 aprile 2025.

2. Proposta di frazionamento inverso delle azioni. Gli investitori hanno autorizzato il Consiglio di Amministrazione, a sua discrezione, a eseguire un frazionamento inverso tra 1 per 2 e 1 per 5 in qualsiasi momento prima del 25 marzo 2026. La misura è stata approvata con decisione con 1.613.691 voti favorevoli, 23.019 contrari e 329 astensioni. Questa flessibilità potrebbe aiutare Xcel a mantenere i requisiti di quotazione Nasdaq aumentando il prezzo per azione.

Non sono state sottoposte ad voto altre questioni. Nel complesso, le approvazioni forniscono alla direzione strumenti migliorati per la raccolta di capitale e la conformità, sebbene comportino potenziali diluizioni e riduzioni del numero di azioni a seconda delle future decisioni.

El 17 de junio de 2025, Xcel Brands, Inc. (NASDAQ: XELB) celebró una Junta Extraordinaria en la que los accionistas votaron sobre dos acciones corporativas clave. Estuvo presente un quórum de 1.637.039 acciones (�68,6% de las 2.386.325 en circulación).

1. Propuesta de ejercicio de warrants. Los accionistas aprobaron, bajo la Regla Nasdaq 5635, la emisión de acciones comunes que exceden el 19,99% de las acciones en circulación tras el ejercicio de warrants relacionados con el refinanciamiento. La moción fue aprobada con 1.020.922 votos a favor, 5.503 en contra, 540 abstenciones y 610.074 votos no emitidos por brokers. La aprobación elimina una barrera regulatoria y permite a la compañía completar los términos del refinanciamiento del 21 de abril de 2025.

2. Propuesta de consolidación inversa de acciones. Los inversores autorizaron a la Junta Directiva, a su discreción, a ejecutar una consolidación inversa entre 1 por 2 y 1 por 5 en cualquier momento antes del 25 de marzo de 2026. Esta medida fue aprobada decisivamente con 1.613.691 votos a favor, 23.019 en contra y 329 abstenciones. La flexibilidad podría ayudar a Xcel a mantener los estándares de cotización en Nasdaq aumentando el precio por acción.

No se sometieron a votación otros asuntos. En conjunto, las aprobaciones brindan a la gerencia herramientas mejoradas para la obtención de capital y el cumplimiento normativo, aunque introducen posibles diluciones y reducción en el número de acciones dependiendo de la ejecución futura.

2025ë…� 6ì›� 17ì�, Xcel Brands, Inc. (NASDAQ: XELB)ì€ íŠ¹ë³„ 주주ì´íšŒë¥� 개최하여 ë‘� 가지 중요í•� 기업 안건ì—� 대í•� ì£¼ì£¼ë“¤ì´ íˆ¬í‘œë¥� 진행했습니다. 2,386,325ì£� ì¤� ì•� 68.6%ì� 1,637,039주가 ì°¸ì„하여 정족수가 충족ë˜ì—ˆìŠµë‹ˆë‹�.

1. 워런íŠ� 행사 제안. ì£¼ì£¼ë“¤ì€ ë‚˜ìŠ¤ë‹� 규칙 5635ì—� ë”°ë¼ ìž¬ìœµìž� ê´€ë � 워런íŠ� 행사 ì‹� 발행 ì£¼ì‹ ìˆ˜ê°€ ì „ì²´ 발행 주ì‹ì� 19.99%ë¥� 초과하는 보통ì£� 발행ì� 승ì¸í–ˆìŠµë‹ˆë‹¤. ì� ì•ˆê±´ì€ ì°¬ì„± 1,020,922í‘�, 반대 5,503í‘�, 기권 540í‘�, 중개ì� 무투í‘� 610,074표로 통과ë˜ì—ˆìŠµë‹ˆë‹�. ì� 승ì¸ì€ 규제 장벽ì� 제거하여 회사가 2025ë…� 4ì›� 21ì� 재융ìž� ì¡°ê±´ì� 완료í•� ìˆ� 있ë„ë¡� 합니ë‹�.

2. ì£¼ì‹ ë³‘í•©(리버ìŠ� 스플ë¦�) 제안. 투ìžìžë“¤ì€ ì´ì‚¬íšŒì— 2026ë…� 3ì›� 25ì� ì´ì „ 언제든지 1대 2ì—서 1대 5 사ì´ì� 리버ìŠ� ìŠ¤í”Œë¦¿ì„ ìž¬ëŸ‰ìœ¼ë¡œ 실행í•� 권한ì� 부여했습니ë‹�. ì� 조치ëŠ� 찬성 1,613,691í‘�, 반대 23,019í‘�, 기권 329표로 ê²°ì •ì ìœ¼ë¡� 통과ë˜ì—ˆìŠµë‹ˆë‹�. ì� ìœ ì—°ì„±ì€ Xcelì� 나스ë‹� ìƒìž¥ 기준ì� 유지하는 ë� ë„움ì� ë� ìˆ� 있으ë©�, 주당 ê°€ê²©ì„ ë†’ì´ëŠ� 효과가 있습니다.

추가 안건ì—� 대í•� 투표ëŠ� 없었습니ë‹�. ì „ì²´ì ìœ¼ë¡� ì´ë²ˆ 승ì¸ìœ¼ë¡œ ê²½ì˜ì§„ì€ ìžë³¸ 조달 ë°� 규정 준수를 위한 ê°•í™”ë� ë„구ë¥� 확보했으ë‚�, 향후 실행ì—� ë”°ë¼ í¬ì„ ë˜ëŠ” ì£¼ì‹ ìˆ� ê°ì†Œ 가능성ë� 존재합니ë‹�.

Le 17 juin 2025, Xcel Brands, Inc. (NASDAQ : XELB) a tenu une Assemblée Générale Extraordinaire au cours de laquelle les actionnaires ont voté sur deux mesures corporatives majeures. Un quorum de 1 637 039 actions (�68,6 % des 2 386 325 actions en circulation) était présent.

1. Proposition d'exercice des bons de souscription. Les actionnaires ont approuvé, conformément à la règle Nasdaq 5635, l'émission d'actions ordinaires dépassant 19,99 % des actions en circulation lors de l'exercice de bons liés au refinancement. La motion a été adoptée avec 1 020 922 voix pour, 5 503 contre, 540 abstentions et 610 074 votes non exprimés par les courtiers. Cette approbation supprime un obstacle réglementaire et permet à la société de finaliser les conditions de refinancement du 21 avril 2025.

2. Proposition de regroupement inversé d'actions. Les investisseurs ont autorisé le Conseil d'administration, à sa discrétion, à réaliser un regroupement inversé entre 1 pour 2 et 1 pour 5 à tout moment avant le 25 mars 2026. Cette mesure a été adoptée de manière décisive avec 1 613 691 voix pour, 23 019 contre et 329 abstentions. Cette flexibilité pourrait aider Xcel à maintenir les critères de cotation Nasdaq en augmentant le cours par action.

Aucune autre question n'a été soumise au vote. Collectivement, ces approbations offrent à la direction des outils renforcés pour la levée de capitaux et la conformité, tout en introduisant des risques potentiels de dilution et de réduction du nombre d'actions selon la mise en œuvre future.

Am 17. Juni 2025 hielt Xcel Brands, Inc. (NASDAQ: XELB) eine außerordentliche Hauptversammlung ab, bei der die Aktionäre über zwei wichtige Unternehmensmaßnahmen abstimmten. Ein Quorum von 1.637.039 Aktien (�68,6 % der 2.386.325 ausstehenden Aktien) war anwesend.

1. Vorschlag zur Ausübung von Warrants. Die Aktionäre genehmigten gemäß Nasdaq-Regel 5635 die Ausgabe von Stammaktien, die bei Ausübung von Refinanzierungsbezogenen Warrants 19,99 % der ausstehenden Aktien überschreiten. Der Antrag wurde mit 1.020.922 Stimmen dafür, 5.503 dagegen, 540 Enthaltungen und 610.074 Broker-Non-Votes angenommen. Die Genehmigung beseitigt eine regulatorische Hürde und ermöglicht es dem Unternehmen, die Refinanzierungsbedingungen vom 21. April 2025 abzuschließen.

2. Vorschlag zur Aktiensplit-Rückführung (Reverse Stock Split). Die Investoren ermächtigten den Vorstand, nach eigenem Ermessen jederzeit vor dem 25. März 2026 eine Rückführung zwischen 1:2 und 1:5 durchzuführen. Diese Maßnahme wurde mit 1.613.691 Stimmen dafür, 23.019 dagegen und 329 Enthaltungen eindeutig angenommen. Die Flexibilität könnte Xcel helfen, die Nasdaq-Listing-Anforderungen durch eine Erhöhung des Aktienkurses einzuhalten.

Weitere Angelegenheiten standen nicht zur Abstimmung. Insgesamt bieten die Genehmigungen dem Management verbesserte Instrumente zur Kapitalbeschaffung und Compliance, bringen jedoch je nach zukünftiger Umsetzung potenzielle Verwässerung und Aktienanzahlreduzierung mit sich.

Positive
  • Regulatory clearance to issue >19.99% new shares removes a key hurdle to completing April 2025 refinancing.
  • Board flexibility to enact a 1-for-2 to 1-for-5 reverse split supports continued Nasdaq listing compliance.
Negative
  • Potential dilution from warrant exercises could materially decrease existing shareholders' ownership percentages.
  • Reverse split risk may reduce share liquidity and sometimes signals underlying share-price weakness.

Insights

TL;DR: Shareholders green-light dilutive warrant issuance and optional reverse split, giving XELB capital and compliance levers; actual impact hinges on execution.

The warrant-exercise approval removes Nasdaq 5635 constraints, allowing the company to honour warrants embedded in its April 2025 refinancing. This could unlock much-needed capital but will dilute existing holders if exercised. The reverse split authority is preventive, aimed at maintaining the minimum bid price for Nasdaq listing. While neither action immediately alters fundamentals, they collectively provide balance-sheet and listing flexibility. Market reaction is likely muted until the board sets a split ratio or warrants convert. Overall, the outcome is strategically positive but financially neutral until exercised.

TL;DR: Governance mechanics intact; votes met quorum, passed cleanly, granting board broad discretion yet signalling potential shareholder dilution.

The meeting followed SEC proxy rules, with clear disclosure and majority support for both proposals. Granting the board unilateral authority for a reverse split without further shareholder input is common for micro-cap issuers but concentrates power. Approval of share issuance beyond the 19.99% cap addresses change-of-control triggers, yet substantially expands authorised share count, affecting voting power. From a governance standpoint, process was transparent, but the potential for dilution and price volatility remains.

Il 17 giugno 2025, Xcel Brands, Inc. (NASDAQ: XELB) ha tenuto un'Assemblea Straordinaria durante la quale gli azionisti hanno votato su due importanti decisioni aziendali. Era presente un quorum di 1.637.039 azioni (circa il 68,6% delle 2.386.325 azioni in circolazione).

1. Proposta di esercizio dei warrant. Gli azionisti hanno approvato, ai sensi della Regola Nasdaq 5635, l'emissione di azioni ordinarie che superano il 19,99% delle azioni in circolazione in seguito all'esercizio di warrant legati al rifinanziamento. La mozione è stata approvata con 1.020.922 voti favorevoli, 5.503 contrari, 540 astensioni e 610.074 voti non espressi dai broker. L'approvazione elimina un ostacolo normativo e permette all'azienda di completare i termini del rifinanziamento del 21 aprile 2025.

2. Proposta di frazionamento inverso delle azioni. Gli investitori hanno autorizzato il Consiglio di Amministrazione, a sua discrezione, a eseguire un frazionamento inverso tra 1 per 2 e 1 per 5 in qualsiasi momento prima del 25 marzo 2026. La misura è stata approvata con decisione con 1.613.691 voti favorevoli, 23.019 contrari e 329 astensioni. Questa flessibilità potrebbe aiutare Xcel a mantenere i requisiti di quotazione Nasdaq aumentando il prezzo per azione.

Non sono state sottoposte ad voto altre questioni. Nel complesso, le approvazioni forniscono alla direzione strumenti migliorati per la raccolta di capitale e la conformità, sebbene comportino potenziali diluizioni e riduzioni del numero di azioni a seconda delle future decisioni.

El 17 de junio de 2025, Xcel Brands, Inc. (NASDAQ: XELB) celebró una Junta Extraordinaria en la que los accionistas votaron sobre dos acciones corporativas clave. Estuvo presente un quórum de 1.637.039 acciones (�68,6% de las 2.386.325 en circulación).

1. Propuesta de ejercicio de warrants. Los accionistas aprobaron, bajo la Regla Nasdaq 5635, la emisión de acciones comunes que exceden el 19,99% de las acciones en circulación tras el ejercicio de warrants relacionados con el refinanciamiento. La moción fue aprobada con 1.020.922 votos a favor, 5.503 en contra, 540 abstenciones y 610.074 votos no emitidos por brokers. La aprobación elimina una barrera regulatoria y permite a la compañía completar los términos del refinanciamiento del 21 de abril de 2025.

2. Propuesta de consolidación inversa de acciones. Los inversores autorizaron a la Junta Directiva, a su discreción, a ejecutar una consolidación inversa entre 1 por 2 y 1 por 5 en cualquier momento antes del 25 de marzo de 2026. Esta medida fue aprobada decisivamente con 1.613.691 votos a favor, 23.019 en contra y 329 abstenciones. La flexibilidad podría ayudar a Xcel a mantener los estándares de cotización en Nasdaq aumentando el precio por acción.

No se sometieron a votación otros asuntos. En conjunto, las aprobaciones brindan a la gerencia herramientas mejoradas para la obtención de capital y el cumplimiento normativo, aunque introducen posibles diluciones y reducción en el número de acciones dependiendo de la ejecución futura.

2025ë…� 6ì›� 17ì�, Xcel Brands, Inc. (NASDAQ: XELB)ì€ íŠ¹ë³„ 주주ì´íšŒë¥� 개최하여 ë‘� 가지 중요í•� 기업 안건ì—� 대í•� ì£¼ì£¼ë“¤ì´ íˆ¬í‘œë¥� 진행했습니다. 2,386,325ì£� ì¤� ì•� 68.6%ì� 1,637,039주가 ì°¸ì„하여 정족수가 충족ë˜ì—ˆìŠµë‹ˆë‹�.

1. 워런íŠ� 행사 제안. ì£¼ì£¼ë“¤ì€ ë‚˜ìŠ¤ë‹� 규칙 5635ì—� ë”°ë¼ ìž¬ìœµìž� ê´€ë � 워런íŠ� 행사 ì‹� 발행 ì£¼ì‹ ìˆ˜ê°€ ì „ì²´ 발행 주ì‹ì� 19.99%ë¥� 초과하는 보통ì£� 발행ì� 승ì¸í–ˆìŠµë‹ˆë‹¤. ì� ì•ˆê±´ì€ ì°¬ì„± 1,020,922í‘�, 반대 5,503í‘�, 기권 540í‘�, 중개ì� 무투í‘� 610,074표로 통과ë˜ì—ˆìŠµë‹ˆë‹�. ì� 승ì¸ì€ 규제 장벽ì� 제거하여 회사가 2025ë…� 4ì›� 21ì� 재융ìž� ì¡°ê±´ì� 완료í•� ìˆ� 있ë„ë¡� 합니ë‹�.

2. ì£¼ì‹ ë³‘í•©(리버ìŠ� 스플ë¦�) 제안. 투ìžìžë“¤ì€ ì´ì‚¬íšŒì— 2026ë…� 3ì›� 25ì� ì´ì „ 언제든지 1대 2ì—서 1대 5 사ì´ì� 리버ìŠ� ìŠ¤í”Œë¦¿ì„ ìž¬ëŸ‰ìœ¼ë¡œ 실행í•� 권한ì� 부여했습니ë‹�. ì� 조치ëŠ� 찬성 1,613,691í‘�, 반대 23,019í‘�, 기권 329표로 ê²°ì •ì ìœ¼ë¡� 통과ë˜ì—ˆìŠµë‹ˆë‹�. ì� ìœ ì—°ì„±ì€ Xcelì� 나스ë‹� ìƒìž¥ 기준ì� 유지하는 ë� ë„움ì� ë� ìˆ� 있으ë©�, 주당 ê°€ê²©ì„ ë†’ì´ëŠ� 효과가 있습니다.

추가 안건ì—� 대í•� 투표ëŠ� 없었습니ë‹�. ì „ì²´ì ìœ¼ë¡� ì´ë²ˆ 승ì¸ìœ¼ë¡œ ê²½ì˜ì§„ì€ ìžë³¸ 조달 ë°� 규정 준수를 위한 ê°•í™”ë� ë„구ë¥� 확보했으ë‚�, 향후 실행ì—� ë”°ë¼ í¬ì„ ë˜ëŠ” ì£¼ì‹ ìˆ� ê°ì†Œ 가능성ë� 존재합니ë‹�.

Le 17 juin 2025, Xcel Brands, Inc. (NASDAQ : XELB) a tenu une Assemblée Générale Extraordinaire au cours de laquelle les actionnaires ont voté sur deux mesures corporatives majeures. Un quorum de 1 637 039 actions (�68,6 % des 2 386 325 actions en circulation) était présent.

1. Proposition d'exercice des bons de souscription. Les actionnaires ont approuvé, conformément à la règle Nasdaq 5635, l'émission d'actions ordinaires dépassant 19,99 % des actions en circulation lors de l'exercice de bons liés au refinancement. La motion a été adoptée avec 1 020 922 voix pour, 5 503 contre, 540 abstentions et 610 074 votes non exprimés par les courtiers. Cette approbation supprime un obstacle réglementaire et permet à la société de finaliser les conditions de refinancement du 21 avril 2025.

2. Proposition de regroupement inversé d'actions. Les investisseurs ont autorisé le Conseil d'administration, à sa discrétion, à réaliser un regroupement inversé entre 1 pour 2 et 1 pour 5 à tout moment avant le 25 mars 2026. Cette mesure a été adoptée de manière décisive avec 1 613 691 voix pour, 23 019 contre et 329 abstentions. Cette flexibilité pourrait aider Xcel à maintenir les critères de cotation Nasdaq en augmentant le cours par action.

Aucune autre question n'a été soumise au vote. Collectivement, ces approbations offrent à la direction des outils renforcés pour la levée de capitaux et la conformité, tout en introduisant des risques potentiels de dilution et de réduction du nombre d'actions selon la mise en œuvre future.

Am 17. Juni 2025 hielt Xcel Brands, Inc. (NASDAQ: XELB) eine außerordentliche Hauptversammlung ab, bei der die Aktionäre über zwei wichtige Unternehmensmaßnahmen abstimmten. Ein Quorum von 1.637.039 Aktien (�68,6 % der 2.386.325 ausstehenden Aktien) war anwesend.

1. Vorschlag zur Ausübung von Warrants. Die Aktionäre genehmigten gemäß Nasdaq-Regel 5635 die Ausgabe von Stammaktien, die bei Ausübung von Refinanzierungsbezogenen Warrants 19,99 % der ausstehenden Aktien überschreiten. Der Antrag wurde mit 1.020.922 Stimmen dafür, 5.503 dagegen, 540 Enthaltungen und 610.074 Broker-Non-Votes angenommen. Die Genehmigung beseitigt eine regulatorische Hürde und ermöglicht es dem Unternehmen, die Refinanzierungsbedingungen vom 21. April 2025 abzuschließen.

2. Vorschlag zur Aktiensplit-Rückführung (Reverse Stock Split). Die Investoren ermächtigten den Vorstand, nach eigenem Ermessen jederzeit vor dem 25. März 2026 eine Rückführung zwischen 1:2 und 1:5 durchzuführen. Diese Maßnahme wurde mit 1.613.691 Stimmen dafür, 23.019 dagegen und 329 Enthaltungen eindeutig angenommen. Die Flexibilität könnte Xcel helfen, die Nasdaq-Listing-Anforderungen durch eine Erhöhung des Aktienkurses einzuhalten.

Weitere Angelegenheiten standen nicht zur Abstimmung. Insgesamt bieten die Genehmigungen dem Management verbesserte Instrumente zur Kapitalbeschaffung und Compliance, bringen jedoch je nach zukünftiger Umsetzung potenzielle Verwässerung und Aktienanzahlreduzierung mit sich.

0001083220false00010832202025-06-172025-06-17

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): June 17, 2025

XCEL BRANDS, INC.

(Exact name of registrant as specified in its charter)

Delaware

    

001-37527

    

76-0307819

(State or Other Jurisdiction
of Incorporation)

(Commission
File Number)

(IRS Employer
Identification No.)

550 Seventh Avenue, 11th Floor, New York, New York

10018

(Address of Principal Executive Offices)

(Zip Code)

Registrant’s telephone number, including area code (347) 727-2474

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below):

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol

Name of each exchange on which registered

Common Stock, par value $0.001 per share

XELB

NASDAQ Global Select Market

Item 5.07. Submission of Matters to a Vote of Security Holders.

On June 17, 2025, Xcel Brands, Inc. (the “Company”) held the Special Meeting at which the Company’s stockholders voted on the following three (3) proposals and cast their votes as described below. These matters are described in detail in the Company’s definitive proxy statement on Schedule 14A, which was filed with the Securities and Exchange Commission (the “Commission”) on May 13, 2025 (the “Proxy Statement”). As of May 7, 2025, the record date of the Special Meeting, there were 2,386,325 shares of Common Stock issued and outstanding and entitled to vote at the Special Meeting. Present in person or by proxy at the Special Meeting were 1,637,039 shares of Common Stock, representing a majority  of the issued and outstanding capital stock present at the  Special Meeting, which constituted a quorum.

The final voting results for each item of business voted upon at the Special Meeting, as described in the Proxy Statement, is set forth below.

Proposal 1. Warrant Exercise Proposal.

The stockholders approved for purposes of complying with Nasdaq Listing Rule 5635 requirements for the issuance of common stock in excess of 19.99% of the Company’s outstanding common stock upon exercise of the warrants to purchase shares of the Company’s common stock issued in connection with the Company’s refinancing which closed on April 21, 2025 (i) which may be deemed a change of control under Rule 5635(b) and (ii) in a transaction not involving a public offering of greater than 20% of the outstanding common stock or voting power prior to the issuance Rule 5635(d) with respect to the Company’s issuance, based on the votes listed below:

Votes For

    

Votes Against

    

Abstentions

    

Broker Non-Votes

1,020,922

5,503

540

610,074

Proposal 2. Reverse Split Proposal.

The stockholders approved the Company to, in the discretion of our Board of Directors, to adopt and approve an amendment to our Amended and Restated Certificate of Incorporation, as amended, to effect a reverse stock of our issued shares of common stock at a ratio within the range of not less than 1-for-2 and not greater than 1-for-5, with the exact ratio within such range and the implementation and timing of such reverse stock split to be determined at the sole discretion of our Board of Directors, without further approval or authorization of our stockholders, at any time prior to March 25, 2026, based on the votes listed below:

Votes For

    

Votes Against

    

Abstentions

    

Broker Non-Votes

1,613,691

23,019

329

0

Both proposals were approved by the Company’s stockholders. The results reported above are final voting results. No other matters were considered or voted upon at the meeting, except a proposal to adjourn the Special Meeting of Stockholders to a later date, if necessary, to permit further solicitation and vote proxies in the event there were not sufficient votes in favor of the Warrant Exercise Proposal and Reverse Stock Split Proposal. Based upon the voting results, the latter was not applicable.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

XCEL BRANDS, INC.
(Registrant)

By:

/s/ James Haran

Name:

James F. Haran

Title:

Chief Financial Officer

Date: June 20, 2025

FAQ

What did XELB shareholders approve at the June 17 2025 Special Meeting?

They approved warrant issuance above Nasdaq’s 19.99% limit and authorised a reverse stock split between 1-for-2 and 1-for-5.

How many votes supported the XELB warrant exercise proposal?

1,020,922 shares voted in favour, versus 5,503 against and 540 abstentions.

What is the range of the authorised reverse stock split for XELB?

The Board may implement a split between 1-for-2 and 1-for-5 any time before 25 March 2026.

Will XELB immediately execute a reverse stock split?

No. The Board now has discretion to decide the timing and exact ratio; no immediate action was announced.

How many shares constituted a quorum at the meeting?

1,637,039 shares of common stock were present in person or by proxy.

Does the warrant approval mean immediate dilution for XELB investors?

Not immediately; dilution occurs only if and when warrant holders exercise their warrants for common shares.

Why did XELB seek authority for a reverse split?

Primarily to maintain Nasdaq listing compliance by potentially increasing its per-share price.
Xcel Brands

NASDAQ:XELB

XELB Rankings

XELB Latest News

XELB Latest SEC Filings

XELB Stock Data

3.52M
1.47M
38.89%
25.19%
1.13%
Apparel Manufacturing
Patent Owners & Lessors
United States
NEW YORK